Live news related to GENFIT stock (FR0004163111): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The Lille biotech is attempting to stabilize after a very difficult month. The stock briefly fell below a technical threshold closely watched by trade…
The Lille-based biotech company specializing in hepatic and metabolic diseases remains under pressure this Friday. The decline occurs in a rising Pari…
Two days after a sharp rebound following the publication of its half-year results, the biotech specialized in liver and metabolic diseases returns to …
The Lille-based biotech company specializing in hepatic and metabolic diseases is regaining ground this Wednesday, posting one of the sharpest rebound…
The Lille-based biotech company specializing in hepatic and metabolic diseases extends its decline this Tuesday, following the publication of its firs…
Genfit published its first half 2026 results on September 28, 2026, marked by cash reserves of €113.8 million and strong growth in royalties from Iqir…
The Lille-based biotech specializing in hepatic and metabolic diseases posts the most marked recovery on the SBF 120 this Monday morning, after severa…
The Lille-based biotech company specializing in hepatic and metabolic diseases continues its correction this Friday morning, consolidating a particula…
The Lille-based biotech specializing in hepatic and metabolic diseases emerges as the worst-performing value in the SBF 120 this Thursday morning, ext…
Genfit is accumulating losses at the start of trading, establishing itself as the worst-performing value on the SBF 120 this Tuesday morning. The decl…
